Lv3
255 积分 2021-10-26 加入
The U.S. Food and Drug Administration’s Perspective on Chimeric Antigen Receptor T-Cell Therapies for Autoimmune and Rheumatic Conditions
10天前
已完结
Dupilumab for COPD with Blood Eosinophil Evidence of Type 2 Inflammation
17天前
已完结
Management of Iron Deficiency in Heart Failure
2个月前
已完结
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
4个月前
已完结
Vericiguat on C-reactive Protein Level and Prognosis in Patients with Hypertensive Heart Failure
4个月前
已完结
Pharmacological Treatment of Heart Failure with Reduced Ejection Fraction: An Updated Systematic Review and Network Meta-Analysis
5个月前
已完结
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial
5个月前
已完结
Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment
5个月前
已完结
Racial and Ethnic Differences in Patient Age at First Hospitalization for Heart Failure
5个月前
已关闭
Prevention of heart failure after acute myocardial infarction
5个月前
已完结
皖公网安备34019202002308
